Risk Reclassification of Patients with Endometrial Cancer Based on Tumor Molecular Profiling: First Real World Data

Recently, guidelines for endometrial cancer (EC) were released that guide treatment decisions according to the tumors’ molecular profiles. To date, no real-world data regarding the clinical feasibility of molecular profiling have been released. This retrospective, monocentric study investigated the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Pers Med
Autori principali: Oberndorfer, Felicitas, Moling, Sarah, Hagelkruys, Leonie Annika, Grimm, Christoph, Polterauer, Stephan, Sturdza, Alina, Aust, Stefanie, Reinthaller, Alexander, Müllauer, Leonhard, Schwameis, Richard
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2021
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7830511/
https://ncbi.nlm.nih.gov/pubmed/33467460
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jpm11010048
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi